DRI Healthcare Trust (TSE:DHT.UN – Get Free Report) had its price objective raised by investment analysts at Stifel Nicolaus from C$22.00 to C$23.00 in a research report issued on Tuesday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective would indicate a potential upside of 41.63% from the company’s current price.
Other analysts have also recently issued reports about the stock. National Bank Financial raised their target price on shares of DRI Healthcare Trust from C$22.50 to C$23.50 and gave the stock an “outperform” rating in a report on Tuesday. Scotiabank raised their target price on shares of DRI Healthcare Trust from C$25.00 to C$30.00 and gave the stock a “sector outperform” rating in a report on Tuesday. Five investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of C$22.30.
Read Our Latest Analysis on DRI Healthcare Trust
DRI Healthcare Trust Price Performance
DRI Healthcare Trust Company Profile
DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.
See Also
- Five stocks we like better than DRI Healthcare Trust
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.
